Developmental Pharmacology and Toxicology: Role of Ontogeny (R03)

The summary for the Developmental Pharmacology and Toxicology: Role of Ontogeny (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Developmental Pharmacology and Toxicology: Role of Ontogeny (R03): This Funding Opportunity Announcement (FOA) encourages grant applications from institutions or organizations that propose multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology. Particular emphasis should be placed on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence affecting drug action and toxicity.
Federal Grant Title: Developmental Pharmacology and Toxicology: Role of Ontogeny (R03)
Federal Agency Name: National Institutes of Health
Grant Categories: Environment Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-13-307
Type of Funding: Grant
CFDA Numbers: 93.113, 93.865
CFDA Descriptions: Environmental Health; Child Health and Human Development Extramural Research
Current Application Deadline: Sep 07, 2016
Original Application Deadline: Sep 07, 2016
Posted Date: Aug 05, 2013
Creation Date: Aug 07, 2013
Archive Date: Oct 08, 2016
Total Program Funding:
Maximum Federal Grant Award: $50,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education
County governments
State governments
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
Native American tribal governments (Federally recognized)
Independent school districts
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public housing authorities/Indian housing authorities
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-13-307.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed...
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advan...
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clini...
Outstanding New Environmental Scientist Award (ONES)
Environmental Health Sciences Core Center Grants
Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com